Fodor János
Országos Onkológiai Intézet, Sugárterápiás Osztály, Budapest.
Magy Onkol. 2007;51(2):127-31. Epub 2007 Jul 29.
The aim of the study was to investigate prognosis of patients who develop an isolated local recurrence (ILR) after conservative surgery (CS) for early-stage invasive breast cancer. Between 1983 and 1987, 415 patients with stage I-II breast cancer were treated with CS. Of these patients, 68 developed an ILR. The mean follow-up time after ILR was 167 months. Cox models taking potential prognostic factors into account were used to estimate the risk of death. On univariate analysis, age (< or =40 vs. >40 years) at first treatment, time to ILR (< or =24 vs. >24 months), type of recurrence (true vs. new primary tumor, NP), and extent of recurrence (operable vs. inoperable) were, but initial tumor stage (pT1 vs. pT2), initial lymph node stage (pN-negative vs. -positive), adjuvant radiotherapy (yes vs. no), type of salvage surgery (wide excision vs. mastectomy), and recurrent tumor grade (1-2 vs. 3) were not significant predictors of post-recurrence survival. On multivariate analysis only time to ILR proved independent predictor of survival (relative risk: 3.2; 95% confidence interval: 1.4-7.3; p = 0.0051), and the age of the patients showed borderline significance (p = 0.0659). The 15-year actuarial rate of cause-specific survival after ILR was 58% for all patients, 60% and 0% for patients with operable or inoperable recurrence, 30% and 71% for patients with age < or =40 or >40 years, 25% and 72% for patients with time to ILR < or =24 or >24 months, 54% and 88% for patients with true recurrence or NP, and 92% for patients with age >40 years with NP, respectively. The rate of second local recurrence after salvage mastectomy or repeated wide excision was 16% and 28%, respectively (p = 0.2265). As a conclusion, many patients with ILR have good prognosis, particularly those with operable recurrence with prolonged time to ILR, or with NP. Salvage mastectomy is not mandatory for all CS patients.
本研究的目的是调查早期浸润性乳腺癌保乳手术(CS)后发生孤立性局部复发(ILR)患者的预后情况。1983年至1987年间,415例I-II期乳腺癌患者接受了保乳手术。其中,68例发生了ILR。ILR后的平均随访时间为167个月。采用考虑潜在预后因素的Cox模型来估计死亡风险。单因素分析显示,初次治疗时的年龄(≤40岁与>40岁)、至ILR的时间(≤24个月与>24个月)、复发类型(真性复发与新发原发性肿瘤,NP)以及复发范围(可手术与不可手术)是有意义的,但初始肿瘤分期(pT1与pT2)、初始淋巴结分期(pN阴性与阳性)、辅助放疗(是与否)、挽救性手术类型(广泛切除与乳房切除术)以及复发肿瘤分级(1-2级与3级)不是复发后生存的显著预测因素。多因素分析显示,仅至ILR的时间被证明是生存的独立预测因素(相对风险:3.2;95%置信区间:1.4-7.3;p = 0.0051),患者年龄显示出临界显著性(p = 0.0659)。所有患者ILR后15年的病因特异性生存率为58%,可手术或不可手术复发患者分别为60%和0%,年龄≤40岁或>40岁患者分别为30%和71%,至ILR时间≤24个月或>24个月患者分别为25%和72%,真性复发或NP患者分别为54%和88%,年龄>40岁的NP患者为92%。挽救性乳房切除术后或重复广泛切除术后的二次局部复发率分别为16%和28%(p = 0.2265)。总之,许多ILR患者预后良好,尤其是那些复发可手术且至ILR时间延长或为NP的患者。并非所有保乳手术患者都必须进行挽救性乳房切除术。